• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » AG Mednet licenses Columbia University software to reduce protocol amendments, unnecessary costs

AG Mednet licenses Columbia University software to reduce protocol amendments, unnecessary costs

November 12, 2012
CenterWatch Staff

Unnecessary procedures and amendments to clinical trial protocols cost sponsors more than $5 billion per year and are responsible for 20% of clinical trial budgets, according to recent research. To help reduce these costs and create zero-delay clinical trials, AG Mednet has licensed from Columbia University advanced image analysis technology developed by Drs. Lawrence Schwartz, Binsheng Zhao and Yongqiang Tan at Columbia University Medical Center.

The software, developed by the Computational Image Analysis Laboratory in the radiology department, aims to verify certain clinical study data prior to submission, a process that could reduce unnecessary procedures, protocol amendments and cost overruns for pharmaceutical clinical trials.

This technology is expected to deliver new quality control modules that check for anatomical completeness of chest, abdomen, pelvis, as well as presence/absence of contrast in CT scans at investigative sites prior to data submission, thus determining whether image sets are protocol compliant before they reach the core lab or sponsor for analysis.

“Compliance with image acquisition requirements is fundamental for proper evaluation in clinical trials,” said Dr. Lawrence Schwartz, professor and chairman of the Department of Radiology, Columbia University Medical Center, who has extensive experience in oncology clinical trials using both conventional and novel imaging modalities. “Our algorithms, together with AG Mednet’s advanced, site-side quality management infrastructure, could help confirm whether the data meets the anatomical completeness requirement and contrast usage at the investigator site prior to data submission. This may significantly cut down on data queries, enhance imaging data quality and enable investigators and adjudicators to reach clear conclusions faster.”

Abraham Gutman, president and CEO, AG Mednet, said, “Dr. Schwartz and his colleagues have created a unique set of algorithms, which adds to AG Mednet’s infrastructure, and we expect that it will provide investigative sites immediate feedback about the quality and compliance of their image sets within clinical trial protocols,”

Boston-based AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, it is a quality compliance partner for image data submission and collection for pharmaceutical, biotechnology and medical device companies, imaging core labs and CROs managing global clinical trials.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing